Table 1.
FDA approved ICIs.
| Name | Target | Approved |
|---|---|---|
| ipilimumab | CTLA-4 | 2011 |
| nivolumab | PD-1 | 2014 |
| pembrolizumab | PD-1 | 2014 |
| atezolizumab | PD-L1 | 2016 |
| avelumab | PD-L1 | 2017 |
| durvalumab | PD-L1 | 2017 |
| cemiplimab | PD-1 | 2018 |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.